Early Detection & Intervention of Cerebral Palsy in Ireland

NCT ID: NCT05907837

Last Updated: 2023-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity.

This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Neurodevelopmental Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol.
* All infants considered high risk for cerebral palsy and neuro-developmental impairment will be eligible, specifically including:

* All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight
* All encephalopathic infants
* Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam)

Exclusion Criteria

* Death prior to discharge from the neonatal unit.
Maximum Eligible Age

40 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Maternity Hospital, Ireland

OTHER

Sponsor Role collaborator

University Maternity Hospital Limerick

UNKNOWN

Sponsor Role collaborator

Cork University Maternity Hospital

OTHER

Sponsor Role collaborator

Coombe Women and Infants University Hospital

OTHER

Sponsor Role collaborator

The Rotunda Hospital

OTHER

Sponsor Role collaborator

Cerebral Palsy Foundation

UNKNOWN

Sponsor Role collaborator

University College Cork

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian H Walsh

Role: PRINCIPAL_INVESTIGATOR

University College Cork

Breda Hayes

Role: PRINCIPAL_INVESTIGATOR

The Rotunda Hospital

Deirdre Sweetman

Role: PRINCIPAL_INVESTIGATOR

National Maternity Hospital

Roy Philips

Role: PRINCIPAL_INVESTIGATOR

Limerick University Maternity Hospital

John Kelleher

Role: PRINCIPAL_INVESTIGATOR

Coombe Women and Infants University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cork University Maternity Hospital

Cork, , Ireland

Site Status RECRUITING

Coombe Women and Infants University Hospital

Dublin, , Ireland

Site Status RECRUITING

National Maternity Hospital

Dublin, , Ireland

Site Status RECRUITING

The Rotunda Hospital

Dublin, , Ireland

Site Status RECRUITING

University Maternity Hospital Limerick

Limerick, , Ireland

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Brian H Walsh

Role: CONTACT

021 42020529

Teresa Berkery

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Brian Walsh

Role: primary

John Kelleher

Role: primary

Deirdre Sweetman

Role: primary

Breda Hayes

Role: primary

Roy Philips

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EDI-CPI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.